Company intelligence / Profile preview

NVIDIA

Santa Clara, California, United States

Ownership: Public · NVDA
Employees: ~29600
Development stage: Commercial

Overview

NVIDIA does not conduct clinical trials or develop therapeutics. Its technologies are widely used by partners in genomics, drug discovery, digital pathology, medical imaging, and robotic surgery to accelerate research and development in healthcare and life sciences. Recent partnerships include collaborations with IQVIA, Illumina, Mayo Clinic, and Arc Institute to advance genomics research and drug discovery using generative AI platforms.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

IQVIAIlluminaMayo ClinicArc InstituteSiemensIBM

Financials

Market cap: $5.4T
Total revenue: $96.2B
Enterprise value: $5.4T

Beyond the preview

Go deeper on NVIDIA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NVIDIA.

Explore the full profile